Live News Categoriesequity

Catalyst Pharmaceuticals Inc (CPRX) News

Track canonical SquawkNews coverage tagged to CPRX, Catalyst Pharmaceuticals Inc. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol CPRX Asset equity Sector Markets 90 days 1 Last 31.49 Updated Jun 30, 2026, 12:09 PM UTC Open live news feed

L Catalyst Pharmaceuticals Announces Topline Results From Two-Part Phase 1 Clinical Study Of Vamorolone In Healthy Adult Volunteers The study demonstrated balanced corticosteroid activity with expected cortisol suppression and no evidence of significant immunosuppressive activity at clinical doses. EQUITY | Jun 30, 2026, 12:09 PM UTC